ABOUT MEDTRACE PHARMA

We are a development stage company aiming to innovate PET diagnostic imaging.

Contact us

Our team

Martin Stenfeldt

CEO

Linkedin-in
Rune Wiik Kristensen

COO

Linkedin-in

Dorte Thulstrup

VP, Regulatory Affairs & Quality assurance

Linkedin-in

Cesare Orlandi

Medical officer

Linkedin-in
Hans Harms, Ph.D.

VP, aQuant Development

René Duvander

Director, commercial business development

Linkedin-in

Karina Kück

coordinator, Regulatory affairs & quality assurance

Linkedin-in

Kasper Lykkegaard Therkelsen

Design & usability lead

Linkedin-in

Teresa Lorrio Gonzales

SOFTWARE DEVELOPer

Linkedin-in

Mark Gockenbach

Coordinator, SoftWare deployment

Linkedin-in

Yumi Murakami

Country manager japan

Linkedin-in
Lars Poulsen Tolbod, Ph.D.

New indications specialist

Peter Larsen, Ph.D.

Advisor, hardware development

Linkedin-in
Jens Soerensen, M.D., Professor

clinical advisor

Mark Lubberink, Professor

scientific advisor

Helle Rasmussen

Bookkeeper

Rebekka Stenfeldt

STUDENT ASSISTANT,
BUSINESS SUPPORT

Katrine Obel

STUDENT ASSISTANT,
Design & Usability Engineering

Alberte Drivsholm

STUDENT ASSISTANT,
Design & Usability Engineering

Our board of directors

Ulrik Spork

Chairman

Linkedin-in
Mads Rasmussen

Vice-chairman

Linkedin-in

Erik Strømqvist

Director

Linkedin-in

Cesare Orlandi

Director

Linkedin-in

Bernt Skov Jensen

Director

Linkedin-in
Jens Soerensen, M.D., Professor

Director

Group 7Created with Sketch.
Michael Frank

Director

Linkedin-in
Group 6Created with Sketch.

”The availability of a reliable approved system for bed-side production of 15O-water could change 15O-water PET from an exotic research tool to a clinical workhorse”

Martin Stenfeldt, CEO, MedTrace Pharma